Trial record 16 of 23 for:
Open Studies | "Jaundice"
Observational Study of Infants Born at 34 to 37 Weeks of Gestation Until the Age of 1 Year
The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2007 by Sheba Medical Center.
Recruitment status was Not yet recruiting
Information provided by:
Sheba Medical Center
First received: October 25, 2007
Last updated: December 24, 2007
Last verified: December 2007
Late preterm infants are at an increased risk for short and long term morbidity (during the 1st year of life, their neurodevelopmental status may also be delayed as compared to infants born at term). The term "near term infants" is probably a deceiving one.
||Observational Model: Case Control
Time Perspective: Prospective
||Late Preterm Infants:Clinical Course and Outcome From Birth Through Out the First Year of Life.
Primary Outcome Measures:
- neurodevelopmental, health and growth status in late preterm infants vs. controls within the first year of life [ Time Frame: one year ] [ Designated as safety issue: No ]
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
The study will include all near term infants born at 3 Israeli medical centers during a one year period.
|Ages Eligible for Study:
||up to 30 Days
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
All infants born at a gestational age of 34-37 weeks in 3 medical centers in Israel
- Gestational age 34wks- 37wks
- Without chromosomal abnormalities or malformations
- No chromosomal abnormalities
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00550069
|Sheba Medical Center
|Tel Hashomer, Israel, 52621 |
|Principal Investigator: Iris Morag, MD |
Sheba Medical Center
||Iris Morag, M.D
||Sheba Medical Center
No publications provided
||Dr. Iris Morag, Sheba Medical Cener
History of Changes
|Other Study ID Numbers:
|Study First Received:
||October 25, 2007
||December 24, 2007
||Israel: Israeli Health Ministry Pharmaceutical Administration
Keywords provided by Sheba Medical Center:
late preterm infants
near term infants
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on July 26, 2014
Glucose Metabolism Disorders
Body Temperature Changes
Signs and Symptoms